Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Jun 2025
Canadian scientists have identified a promising therapeutic target to attack to prevent breast cancer from recurring: the protein PIK3C3.
Read Full NewsNot all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Dr Maurie Markman examines new registry data on ovarian cancer diagnostic timing, showing how disease biology can complicate the link between early detection and survival.
Dr Andrea Chadwick describes how the shift from tender points to symptom-based criteria has improved fibromyalgia diagnosis, understanding, and patient-centered care.
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes.
Before you freeze a skin lesion, ask yourself whether you really know what it is. Here are four signs you should biopsy instead of freeze.
EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, sending its...
The FDA has approved a radioactive agent for use in brain scans to help assess patients for Alzheimer's disease.
1.
Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.
2.
Study identifies new target for obesity-related breast cancer
3.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
4.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
5.
Skipping Lymph Node Biopsy Gains Ground in Breast Cancer
1.
Unlocking The Power Of Cangrelor To Treat Heart Disease
2.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
3.
Emerging Therapies Using Tumor Evolution Interruption Technologies
4.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
5.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge